期刊文献+

不同钙浓度枸橼酸透析液对血钙和甲状旁腺激素水平的影响 被引量:7

Different calcium concentration Citrate dialysate consequences on calcium and PTH in hemodialysis patients
原文传递
导出
摘要 目的比较不同钙浓度枸橼酸盐透析液对维持性血液透析患者血钙和甲状旁腺激素(PTH)水平的影响。对比分析二代PTH(全段,intactPTH)和三代laTH(活性全段,biointactPTH1.84)检测与血钙和PTH的相关度。方法15例长期维持性血液透析(MHD)患者每周接受不同钙浓度的枸橼酸透析液治疗,透析液钙浓度分别为1.75mmol/L(DCa1.75)、1.5mmol/L(DCa1.5)和1.25mmol/L(DCa1.25)。采用自身前后对照研究方法,比较不同钙浓度枸橼酸透析液对患者透析前、后血清总钙(tCa)、离子钙(iCa)、全段PTH(iPTH)、活性全段PTH(bio.iPTH)水平的影响。结果(1)与透析前相比,DCa1.75组患者透析后tCa、iCa水平升高(P〈0.05),PTH有下降趋势;DCa1.5组透析后tCa、iCa水平差异无统计学意义,但PTH较透析前升高;DCa1.25组透析后tCa、iCa均低于透析前(P〈0.05),PTH较透析前升高。(2)两种PTH检测结果提示,iPTH绝对数明显高于bio.iPTH,两者有良好的相关性(R=0.98)。与iPTH相比,bio.iPTH变化与血钙浓度变化有更好的相关度。结论DCa1.75、DCa1.5mmol/L枸橼酸透析液单次透析后能更好地维持血透患者的血钙稳定,对胛H影响相对较小。检测bio.iPTH较iPTH能更好地反映由钙浓度变化导致的体内活性PTH改变。 Objective To evaluate the effects on the mineral bone disorder using different calcium eoneentration citrate-based dialysate in maintenance hemodialysis (MHD) patients. To compare the concentrations of intact parathyroid hormone(PTH) with biointact PTH(1- 84) in these patients. Methods Citrate dialysate with different calcium concentration (DCa 1.75, DCa 1.5, DCa 1.25 mmol/L) were used in turn in 15 stable MHD patients each week. Serum tCa and iCa were measured by automatie biochemistry analyzer. The concentrations of iPTH and bio-iPTH were compared. Results (1) The patients treated with DCa 1.75 citrate dialysate had increased serum iCa and tCa after dialysis, and PTH did not change significantly as compared to those findings before the dialysis. With the DCa 1.5 eitrate dialysate, serum iCa and tCa were kept stable and PTH level was increased. With DCa 1.25 eitrate dialysate, serum iCa and tCa decreased signifieantly and PTH decreased. (2)iPTH and bioPTH had excellent correlations. Variation of bio-iPTH was more correlated with the changes of calcium than iPTH. Conclusions Serum levels of iPTH, tCa and iCa can be kept stable in MHD patients treatedwith DCa 1.75 ~ 1.5 citrate dialysate. Bio-iPTH is a more sensitive marker for mineral bone disease than iPTH.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2015年第2期109-114,共6页 Chinese Journal of Nephrology
基金 基金项目:十二五科技支撑计划(2011BA110800) 北京市科技基金(D131100004713001)
关键词 透析液 血清 甲状旁腺激素 血液透析 Dialysate Calcium, serum Parathyroid hormone Hemodialysis
  • 相关文献

参考文献16

  • 1Gabutti L, Lucchini B, Marone C, et al. Citrate vs. acetate- based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes [J]. BMC Nephrol, 2009, 10(5): 7.
  • 2Kuragano T, Kida A, Furuta M, et al. Effects of acetate- free citrate-containing dialysate on metabolic acidosis, anemia, and malnutrition in hemodialysis patients[J]. Artif Organs, 2012, 36 (3): 282-290.
  • 3Grundstrom G, Christensson A, Alquist M, et al. Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility[J]. BMC Nephrol, 2013, 14(10): 216.
  • 4Ahmad S, Callan R, Cole JJ, et al. Dialysate made from dry chemicals using citric acid increases dialysis dose[J]. Am J Kidney Dis, 2000, 35(3): 493-499.
  • 5Ahmad S, Callan R, Cole J, et al. Increased dialyzer reuse with citrate dialysate[J]. Hemodial Int, 2005, 9: 264-267.
  • 6Kuragano T, Kida A, Furuta M, et al. Effects of acetate- free citlate-containing dialysate on metabolic acidosis, anemia, and malnutrition in hemodialysis patients[J]. Artif Organs, 2012, 36 (3): 282-290.
  • 7徐斌,金波,季大玺,龚德华,刘志红.枸橼酸碳酸氢盐透析液对血液透析患者高血压的影响[J].肾脏病与透析肾移植杂志,2010,19(5):424-429. 被引量:12
  • 8韩雪,丁嘉祥,郭王,刘静,刘文虎.不同缓冲剂碳酸盐透析液对维持性血液透析患者血压及血钙的影响[J].中国血液净化,2014,13(8):573-576. 被引量:4
  • 9贾利宁,杨阳,桂保松,田普训.枸橼酸碳酸氢盐血液透析液对外周细胞因子和NOS的影响[J].陕西医学杂志,2009,38(3):303-305. 被引量:2
  • 10Basile C, Libutti P, Lomonte C. The diffusion gradient between the ionized calcium concentration in the dialysate and in the blood is the main driving force of the net calcium mass balance during haemodialysis[J]. Nephrol Dial Transplant, 2010, 25(4): 1356-1357.

二级参考文献28

  • 1陈香美,张冬.应重视维持性血液透析患者微炎症状态的认识[J].中国血液净化,2005,4(2):59-61. 被引量:102
  • 2肖申,季大玺,季曙明,胡维新.醋酸盐和无醋酸碳酸氢盐血透病人外周血IL-6、TNF和淋巴细胞亚群的变化[J].中华肾脏病杂志,1995,11(3):163-165. 被引量:9
  • 3Veech RL. The untoward effects of the anions dialysis fluids .Kidney Int, 1988, 34: 587-597.
  • 4Pizzarelli F, Cerrai T, Ferro G, et al . On-line hemodiafiltration without acetate. G Ital Nefrol, 2004, 21 Suppl 30:S97-101.
  • 5Boenisch O,Ehmke KD, Heddergott A, et al . C-reactive protein levels in hemodialysis patients. J Am Soc Nephrol, 2002, 15:547-551.
  • 6Amore A, Conti G, Cirina P, et al. Biocompatibility of the acetate in the dialysis fluid . G Ital Nefrol, 2004, 21 Suppl 30:S91-96.
  • 7Amore A, Cirina P, Mitola S,et al . Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. J Am Soc Nephrol, 1997, 8:1431- 1436.
  • 8Cavalcanti S,Ciandrini A,Severi S,et al.Model-based study of the effects of the hemodialysis technique on the compensatory response to hypovolemia[J].Kidney Int,2004,65:1499-1510.
  • 9Todeschini M,Macconi D,Fernandez NG,et al.Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation[J].Am J Kidney Dis,2002,40:783-793.
  • 10de Vries JP,Kouw PM,van der Meer NJ,et al.Non-inva sive monitoring of blood volume during hemodialysis:its relation with post-dialytic dry weight[J].Kidney Int,1993,44:851-854.

共引文献12

同被引文献70

  • 1Kuragano T, Kida A, Furuta M. Effects of acetate-free citrate- containing dialysate on metabolic acidosis, anemia, and malnutrition in hemodialysispatients[J].Ar- tif Organs, 2012, 36(3):282-290.
  • 2Gabutti L, Lucchini B, Marone C, et al. Citrate vs. ace- tate-based dialysate in bicarbonate haemodynamics, co- agulation, acid- base status, and electrolytes[J]. BMC Nephrol, 2009, 10(5):7-7.
  • 3Grandi E, Govoni M, Furini S, et al. Induction of No synthase 2 in ventricular cardiomyocytes incubated with a conventional bicarbonate dialysis bath[J]. Nephrol Dial Transplant, 2008, 23(7):2192-2197.
  • 4Bolasco P, Ghezzi PM, Serra A, et al. Effects of ace- tate- free haemodiafiltration (HDF) with endogenous re- infusion (HFR) on cardiac troponin ]evels[J].Nephrol Dial Transplant, 2011, 26(1):258-263.
  • 5Ahmad S, Callan R, Cole JJ, et al. Dialysate made from dry chemicals using citric acid increases dialysis dose [J].Am J Kidney Dis, 2000, 35(3):493-499.
  • 6Ahmad S, Callan R, Cole JJ, et al. Increased dialyzer reuse with citrate dialysate[J].Hemodial Int, 2005, 9 (3):264-267.
  • 7Saito T, Saito O, Maeda T, et al. Metabolic and hemody- namic advantages of an acetate- free citrate dialysate in a uremic case of congenital methylmalonic academia [J].hm J Kidney Dis, 2009, 54(4):764-769.
  • 8Rocha AD, Padua VC, 01iveira E, et al, Effects of ci- trate-enriched bicarbonate based dialysate on anticoag-ulation and dialyzer reuse in maintenancehemodialysis patients[J].Hemodial Int, 2014, 18(2):467-472.
  • 9Karlien F, Karl , Rita J, et al. Avoidance of system- ic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and ci- trate-enriched dialysate: a retrospective cohort study [J].BMC Nephrology, 2014, 15(3):i04-ii0.
  • 10Yuk-Lun C, Alex WY, Kwong-Yuen T, et al. Anticoagula- tion during haemodialysis using a citrate-enriched di- alysate: a feasibility study[J].Nephrol Dial Trans- plant, 2011, 26(2):641-646.

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部